You're listening to Plenary Session.

This week on Plenary Session, you're in for a real treat.

We're back here in the Plenary Session H.Q, and I'm going to take you through three papers that appeared in Nature Medicine on the topic of precision oncology.

I had a chance to read these and apply my highlighter to them, and you won't want to miss this discussion of three important articles.

Next, we received a letter from Dr. Arjun Gupta, who is a first-year hematology oncology fellow at Johns Hopkins University.

He wanted to discuss a randomized

controlled trial of an intervention for mucusitis. And per request, he's coming on the podcast to

take us through the data and what the limitations may be. Finally, I'm back in Plenary Session H.Q with

Talal Hillal. And we're going to talk a little bit about some of the broader implications of the precision

oncology studies that I've just taken you through.

You won't want to miss this week's discussion here on Plenary Session.

But first, a plug.

If you like this episode and you like this podcast, I need you to do three things.

One, go to patreon.com and back this podcast.

Backing an artist you support on patreon.com is a great way to keep something going.

Next, go to the iTunes store and don't just give us five stars.

Write a review.

Tell us what you like about the podcast and what you don't like.

A written review goes a long way.

Third, recommend plenary session to a friend. If you have a friend, a colleague, someone you think is going to like this podcast, give them a recommendation. We can use it on plenary session.

Now, what can plenary session do for you? Well, we can answer your questions.

Tweet to us at Plenary underscore Session or send us an email at Plenary Session Podcast at

...